“Oral Nalbuphine Extended-Release Is Effective in Severe Prurigo Nodularis–Associated Pruritus: Results From a Phase 2b/3, Double-Blind, Placebo-Controlled Study”, J of Skin, vol. 6, no. 6, p. s103, Nov. 2022, doi: 10.25251/skin.6.supp.103.